Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?

International Journal of Antimicrobial Agents

Volumn 29, Issue 5, 2007, Pages 605-607

  Miller, Loren G ^a   Mehrotra, Rajnish ^a   Tang, Angela W ^b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b ST MARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; CALCULATION; CASE REPORT; CLINICAL FEATURE; DRUG RESPONSE; DYSURIA; FEMALE; HEMATURIA; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; URINARY TRACT INFECTION; URINARY URGENCY; URINE CULTURE;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; PREDICTIVE VALUE OF TESTS; TREATMENT FAILURE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS;

EID: 34147098139     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.11.021     Document Type: Letter

References (7)

1. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29 (1999) 745-758
2. Daza R., Gutierrez J., and Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents 18 (2001) 211-215
3. Stamey T.A., Fair W.R., Timothy M.M., Millar M.A., Mihara G., and Lowery Y.C. Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. N Engl J Med 291 (1974) 1159-1163
4. The ASCAP Panel. Community-Acquired Pneumonia (CAP) Year 2002: Antibiotic Selection and Management Update. http://www.ahcpub.com/ahc_root_html/hot/archive/ascap2002.html [accessed 15 April 2004].
5. Centers for Disease Control and Prevention (CDC). Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae-United States, 2003. MMWR Morb Mortal Wkly Rep 53 (2004) 152-154
6. Raz R., Chazan B., Kennes Y., et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 34 (2002) 1165-1169
7. Sanchez Navarro M.D., Milano C.C., Castaneda A.Z., Sayalero Marinero M.L., and Sanchez-Navarro A. Pharmacokinetics of ciprofloxacin as a tool to optimise dosage schedules in community patients. Clin Pharmacokinet 41 (2002) 1213-1220